Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

DOTATATE uptake is higher in mCRPC patients with neuroendocrine transformation

Feb. 26, 2020

[68Ga]PSMA-11 PET/CT has a large effect on prostate cancer staging and management

Feb. 20, 2020

Novartis studies BLZ-945 in phase II trial for ALS

Feb. 12, 2020

FDA approves first human trials of Myeliviz for PET imaging in MS

Jan. 29, 2020

AC Immune patents alpha-synuclein-targeting compounds for PET imaging

Dec. 31, 2019

PET imaging agent PyL meets primary endpoint in phase III prostate cancer trial

Dec. 24, 2019

New adenosine A2A receptor antagonists identified at Evotec, Ex Scientia

Dec. 20, 2019

[18F]GTP-1 imaging shown to be useful to detect cognitive decline

Dec. 17, 2019

89Zr-DFO-MSTP-2109A shows promise as companion diagnostic in patients with mCRPC

Dec. 4, 2019

First-in-human study of 89Zr-DFO-REGN-3504 for imaging PD-L1 tumors

Nov. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...